期刊文献+

草分枝杆菌制剂对大鼠膀胱癌的抑制作用 被引量:3

Inhibitory effects of Mycobacterium phlei on bladder cancer in rats
下载PDF
导出
摘要 目的探讨草分枝杆菌制剂连续膀胱灌注对大鼠膀胱肿瘤生长的抑制作用和机制。方法40只雌性Wistar大鼠,随机分为对照组(n=20)和草分枝杆菌组(n=20),制作N-甲基亚硝基脲诱导大鼠原位膀胱癌模型,于第8周开始分别行生理盐水和草分枝杆菌制剂连续膀胱灌注,每周1次,共6次。于第14周进行病理观察、测量膀胱总重量,微血管密度(MVD)和凋亡指数(AI)。结果第14周时,对照组(n=16)和草分枝杆菌组(n=14)大鼠膀胱均可见明显肿物,光镜下可见癌组织侵入肌层。草分枝杆菌组大鼠膀胱的重量和肿瘤的MVD小于对照组(t=2.609,P=0.048;t=2.124,P=0.043);草分枝杆菌组大鼠膀胱肿瘤的AI小于对照组但无统计学意义(t=0.583,P=0.565)。结论草分枝杆菌制剂连续膀胱灌注可抑制大鼠膀胱肿瘤生长,可能与抑制肿瘤血管生长有关。 Objective To investigate the inhibitory effects of Mycobacterium phlei preparation on orthotopic bladder carcinoma in rats and its mechanism. Methods Forty female Wistar rats were randomly divided equally into two groups: group I received normal saline plus N-methylnitrosourea as control and group Ⅱ received M. phlei preparation by intravesical perfusion (once a week for 6 weeks) for developing animal models. At week 14, the bladder weight, pathologic changes, rnicroveasel density(MVD) and apoptosis indexes(AI) were surveyed. Results There were obvious tumors in the both groups ( n = 16 in group Ⅰ and n = 14 in group Ⅱ ) at week 14. The tumors cells were infiltrated into the muscular layer of bladder. The bladder weights and MVDs were significandy lower in group Ⅱ than in group I ( P 〈 0.05 for both), but there was no significant difference in AI between both groups ( P = 0. 565). Conclusion Mycobacterlum phlei can inhibit the bladder tumor growth by restraining angiogenesis in rats.
出处 《山西医科大学学报》 CAS 2006年第5期493-494,502,共3页 Journal of Shanxi Medical University
关键词 膀胱肿瘤 草分枝杆菌制剂 新生血管化 病理性 细胞凋亡 大鼠 WISTAR bladder neoplasms Mycobacterium phlei preparation neovascularization, pathologic~ apoptosis rats, Wistar
  • 相关文献

参考文献7

  • 1Schenkman E,Lamm DL.Superficial bladder cancer therapy[J].Sci World,2004,4(Suppl 1):387-399.
  • 2Morales A,Chin JL,Ramsey EW.Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder[J].J Urol,2001,166:1633-1638.
  • 3刘红耀,李晓东,米振国,王东文,李春华,李柄太,佟锦.N-甲基亚硝基脲的制备及其诱发膀胱肿瘤的作用[J].中华实验外科杂志,2000,17(6):548-549. 被引量:23
  • 4Steinberg GD,Brendler CB,Squire RA,et al.Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model[J].J Urol,1991,145:647-653.
  • 5Pavlovich CP,Kraling BM,Stewart RJ,et al.BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation[J].J Urol,2000,163:2014-2021.
  • 6Rocchetti R,Talevi S,Margiotta C,et al.Antiangiogenic drugs for chemotherapy of bladder tumours[J].Chemotherapy,2005,51:291-299.
  • 7Brown NS,Streeter EH,Jones A,et al.Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species:the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma[J].Br J Cancer,2005,92:1696-1701.

二级参考文献3

  • 1Irving CC,Cox R,Murphy WM,et al.Influence of dose of N-nitrosourea on the induction of urinary bladder cancer in rats[].Cancer Letters.1979
  • 2Hicks RM.Multistage cacinogenesis in the urinary bladder[].British Medical Bulletin.1980
  • 3Serers NJ,Barnes SH,Wright R,et al.Induction of bladder cancer in rats by fractionated intravesicular doses of N-methyl-N-nitrosourea[].British Journal of Cancer.1982

共引文献22

同被引文献33

  • 1李兵,鹿红,臧静.肺腺癌细胞株SPC-A-1细胞存活曲线参数的测定[J].南京医科大学学报(自然科学版),2005,25(1):41-43. 被引量:1
  • 2张超,马成民,马克,陈红兵,李波.乌体林斯膀胱灌注预防浅表性膀胱癌复发[J].中国临床保健杂志,2005,8(3):262-263. 被引量:4
  • 3张天禹,覃展偶,葛波,蒋雷鸣.乌体林斯膀胱灌注预防复发浅表膀胱癌术后再复发47例分析[J].广西医学,2005,27(9):1429-1430. 被引量:3
  • 4Mallick BB, Kishore S, Das SK, et al. Nonspecific immunostimulation against viruses[J]. Comp Immunol Microbiol Infect Dis, 1985,8( 1 ) : 53-63.
  • 5Baldridge JR, Ward JR. Effective adjusants for the induction of antigen- specific delayed-type hypersensitivity[J]. Vaccine, 1997, 15(4) : 395- 401.
  • 6Gray GR, Ribi E, Granger D, et al. Immunotherapy of cancer :tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets[J] .J Natl Cancer Inst, 1975,55(3):727-730.
  • 7Adams JL, Czuprynski CJ. Ex vivo induction of TNF-alpha and IL-6 mRNA in bovine whole blood by Mycobacterium paratuberculosis and mycobacterial cell wall components [ J ]. Microb Pathog, 1995,19 (1): 19-29.
  • 8Roach SK, Schorey JS. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria[J]. Infect Immun, 2002,70( 6 ) : 3040-3052.
  • 9Chin JL, Kadhim SA, Batislam E, et al. Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guefin (BCG) therapy in orthotopic routine bladder cancer[J] .J Urol, 1996,156(3) : 1189-1193.
  • 10Morales A, Nickel JC, Downey J,et al. Immunotherapy of an experimental adenocarcinoma of the prostate [ J ]. J Urol, 1995,153 (5) : 1706- 1710.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部